REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
17/03/2025
Voltar para busca
Dado oficial do USPTO
ENERZAIR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
17/03/2025
Tipo de marca
Mista
Classes Nice
5
Data de depósito
16/04/2019
Data de registro
17/03/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/03/2020
Última transação
17/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
25
Localização do titular
CH
Examinador
ORTIGA PALMER, RAMONA
Unidade examinadora
M80
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "ENERZAIR" in green preceded by a design resembling an upside-down diamond comprising two segments where the bottom segment comprises three connected triangles in varying shades of yellow and where the top segment's left half comprises two connected triangles in varying shades of green and the right half comprises two connected triangles in varying shades of blue.
Titulares e representantes
Titulares
NOVARTIS AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
07/08/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
23/07/2020
FIMP
FINAL DISPOSITION PROCESSED
23/07/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/06/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
17/03/2020
GPNX
NOTIFICATION PROCESSED BY IB
04/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/12/2019
PUBO
PUBLISHED FOR OPPOSITION
31/12/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/12/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/09/2019
RFNT
REFUSAL PROCESSED BY IB
06/09/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/08/2019
RFRR
REFUSAL PROCESSED BY MPU
22/08/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/07/2019
CNRT
NON-FINAL ACTION WRITTEN
28/07/2019
MAFR
APPLICATION FILING RECEIPT MAILED
23/07/2019
DOCK
ASSIGNED TO EXAMINER
18/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/07/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/07/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/06/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ENERZAIR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.